Yu-Jung "Jenny" Wei,
Assistant Professor
Department:
Pharmaceutical Outcomes & Policy
Business Phone:
(352) 273-6268
Business Email:
jenny.wei@ufl.edu
Teaching Profile
Courses Taught
2016-2018,2020-2023
PHA6910 Supervised Research
2020-2022
PHA6938 Research Seminar
2016-2018,2020-2022
PHA7979 Advanced Research
2018-2022
PHA6265 Introduction to Pharmaceutical Outcomes and Policy I
2017-2021
PHA5223 P-Epidem Drug Safety
2021
PHA7807 Advanced Pharmacoepidemiology
2017-2018,2021
PHA6971 Research for Master’s Thesis
2019-2021
PHA6940 Supervised Teaching
2016-2021
PHA6937 Topics in Pharmaceutical Administration
2016-2017,2019-2021
PHA6936 Advanced Topics in Pharmaceutical Sciences
2016-2018,2020-2021
PHA7980 Research for Doctoral Dissertation
2016,2019-2020
PHA6935 Selected Topics in Pharmacy
2016-2018
PHA5878C Pt Care 3: Cv and Pulm
2017
PHA6266 Introduction to Pharmaceutical Outcomes and Policy II
2017
PHA6268 Pharmacoepidemiology and Patient Safety
2016
PHA6805 Applied Data Interpretation and Reporting of Findings in Pharmacy
Research Profile
Open Researcher and Contributor ID (ORCID)
0000-0001-8861-6907
Publications
2024
Pain intensity, physical function, and depressive symptoms associated with discontinuing long‐term opioid therapy in older adults with Alzheimer’s disease and related dementias
Alzheimer's & Dementia.
20(2):1026-1037
[DOI] 10.1002/alz.13489.
[PMID] 37855270.
2024
Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer’s disease and related dementia
Age and Ageing.
53(3)
[DOI] 10.1093/ageing/afae047.
[PMID] 38497237.
2024
Sociodemographic Characteristics of Adverse Event Reporting in the USA: An Ecologic Study
Drug Safety.
47(4):377-387
[DOI] 10.1007/s40264-024-01397-6.
[PMID] 38353883.
2022
Association of injury after prescription opioid initiation with risk for opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case-control study
PLOS Medicine.
19(9)
[DOI] 10.1371/journal.pmed.1004101.
[PMID] 36136971.
2022
Concurrent use of prescription gabapentinoids with opioids and risk for fall-related injury among older US Medicare beneficiaries with chronic noncancer pain: A population-based cohort study
PLOS Medicine.
19(3)
[DOI] 10.1371/journal.pmed.1003921.
[PMID] 35231025.
2022
Concurrent Use of Prescription Opioids and Gabapentinoids in Older Adults
American Journal of Preventive Medicine.
62(4):519-528
[DOI] 10.1016/j.amepre.2021.08.024.
[PMID] 34802816.
2022
Discontinuation of Long-Term Opioid Therapy in Patients With Versus Without Dementia
American Journal of Preventive Medicine.
62(2):270-274
[DOI] 10.1016/j.amepre.2021.07.020.
[PMID] 34702606.
2022
Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims data.
Pharmacoepidemiology and drug safety.
31(1):100-104
[DOI] 10.1002/pds.5371.
[PMID] 34657354.
2022
Perioperative Use of Gabapentinoids and Risk for Postoperative Long-Term Opioid Use in Older Adults Undergoing Total Knee or Hip Arthroplasty.
The Journal of arthroplasty.
37(11):2149-2157.e3
[DOI] 10.1016/j.arth.2022.05.018.
[PMID] 35577053.
2022
Trajectories of prescription opioid dose and risk of opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case–control study
PLOS Medicine.
19(3)
[DOI] 10.1371/journal.pmed.1003947.
[PMID] 35290389.
2021
Agreement of Minimum Data Set 3.0 depression and behavioral symptoms with clinical diagnosis in a nursing home
Aging & Mental Health.
25(10):1897-1902
[DOI] 10.1080/13607863.2020.1758921.
[PMID] 32447973.
2021
Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes.
Diabetes care.
44(6):1344-1352
[DOI] 10.2337/dc20-1794.
[PMID] 33875487.
2021
Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia
Alzheimer's Research & Therapy.
13(1)
[DOI] 10.1186/s13195-021-00818-3.
[PMID] 33883028.
2021
Response to Comment on Albogami et al. Glucagon-Like Peptide-1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352.
Diabetes care.
44(8)
[DOI] 10.2337/dci21-0024.
[PMID] 34285101.
2021
Uncontrolled Pain and Risk for Depression and Behavioral Symptoms in Residents With Dementia
Journal of the American Medical Directors Association.
22(10):2079-2086.e5
[DOI] 10.1016/j.jamda.2021.05.010.
[PMID] 34089652.
2021
Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018.
Pain medicine (Malden, Mass.).
22(10):2153-2161
[DOI] 10.1093/pm/pnab088.
[PMID] 33690860.
2020
Risk of Opioid Overdose Associated With Concomitant Use of Opioids and Skeletal Muscle Relaxants: A Population-Based Cohort Study.
Clinical pharmacology and therapeutics.
108(1):81-89
[DOI] 10.1002/cpt.1807.
[PMID] 32022906.
2020
Towards Automating Adverse Event Review: A Prediction Model for Case Report Utility
Drug Safety.
43(4):329-338
[DOI] 10.1007/s40264-019-00897-0.
2020
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract-Quantifying the misclassification of maternal drug exposure during pregnancy.
Pharmacoepidemiology and drug safety.
29(11):1414-1422
[DOI] 10.1002/pds.5126.
[PMID] 32909348.
2019
Body weight, frailty, and chronic pain in older adults: a cross-sectional study
BMC Geriatrics.
19(1)
[DOI] 10.1186/s12877-019-1149-4.
[PMID] 31126233.
2019
Concomitant Use of Quinolones and Stimulants and the Risk of Adverse Cardiovascular Symptoms: A Retrospective Cohort Study.
Pharmacotherapy.
39(12):1167-1178
[DOI] 10.1002/phar.2343.
[PMID] 31674031.
2019
Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis.
Drug and alcohol dependence.
202:172-177
[DOI] 10.1016/j.drugalcdep.2019.05.025.
[PMID] 31352307.
2019
Pain Assessments in MDS 3.0: Agreement with Vital Sign Pain Records of Nursing Home Residents.
Journal of the American Geriatrics Society.
67(11):2421-2422
[DOI] 10.1111/jgs.16122.
[PMID] 31403708.
2019
Performance of the Centers for Medicare & Medicaid Services’ Opioid Overutilization Criteria for Classifying Opioid Use Disorder or Overdose.
JAMA.
321(6):609-611
[DOI] 10.1001/jama.2018.20404.
[PMID] 30747958.
2019
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
Inflammatory bowel diseases.
25(8):1417-1427
[DOI] 10.1093/ibd/izz001.
[PMID] 30839057.
2019
Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study
PLOS Medicine.
16(11)
[DOI] 10.1371/journal.pmed.1002941.
[PMID] 31689302.
2019
Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016
Drug and Alcohol Dependence.
204
[DOI] 10.1016/j.drugalcdep.2019.107600.
[PMID] 31586806.
2018
Azithromycin and Sensorineural Hearing Loss in Adults: A Retrospective Cohort Study.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
39(8):957-963
[DOI] 10.1097/MAO.0000000000001887.
[PMID] 29965935.
2018
Clinical utility and perils of prescription drug monitoring program-based alert systems.
Pain.
159(4):804-805
[DOI] 10.1097/j.pain.0000000000001157.
[PMID] 29557901.
2018
Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
JAMA network open.
1(4)
[DOI] 10.1001/jamanetworkopen.2018.1152.
[PMID] 30646105.
2018
The association of antidepressant treatment with COPD maintenance medication use and adherence in a comorbid Medicare population: A longitudinal cohort study
International Journal of Geriatric Psychiatry.
33(2)
[DOI] 10.1002/gps.4772.
[PMID] 28833488.
2017
Physical Health Outcomes in Preschoolers with Prior Authorization for Antipsychotics.
Journal of child and adolescent psychopharmacology.
27(9):833-839
[DOI] 10.1089/cap.2017.0006.
[PMID] 28708433.
2016
Effects of cognitive overweight status on food choice.
Health marketing quarterly.
33(4):386-401
[PMID] 27786610.
2009
Local and collective motions in precise polyolefins with alkyl branches: a combination of 2H and 13C solid-state NMR spectroscopy.
Angewandte Chemie (International ed. in English).
48(25):4617-20
[DOI] 10.1002/anie.200900377.
[PMID] 19437520.
2009
Precision polyethylene: changes in morphology as a function of alkyl branch size.
Journal of the American Chemical Society.
131(47):17376-86
[DOI] 10.1021/ja907521p.
[PMID] 19891434.
Grants
Sep 2019
– Aug 2022
Prescription Opioid Use Trajectories and Risk Factors Associated with Opioid-Related Hospitalizations in Older Adults
Role: Principal Investigator
Funding: AGENCY FOR HEALTHCARE RES AND QUALITY
Aug 2017
– May 2022
Pharmacological Management of Pain in Alzheimer's Disease and Related Dementia
Role: Principal Investigator
Funding: NATL INST OF HLTH NIA
Mar 2016
– May 2017
Medicaid Drug Therapy Management Program for Behavioral Health
Role: Principal Investigator
Funding: UNIV OF SOUTH FLORIDA
via CTRS FOR MEDICARE & MEDICAID SERVICES
Contact Details
Phones:
- Business:
- (352) 273-6268
Emails:
- Business:
- jenny.wei@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 100496
GAINESVILLE FL 32610 - Business Street:
-
PO Box 100496
GAINESVILLE FL 32610